The healthcare company will add new members to their teams while others expand their roles, and some retire from them.
A new year brings new moves for The Cigna Group who just announced they are making leadership changes aimed at boosting growth across their subsidiaries Evernorth Health Services and Cigna Healthcare.
Shared in a release January 17, the healthcare company will add new members to their teams while others expand their roles, and some retire from them.
Within The Cigna Group, Ann Dennison, CPA, will take on the role as deputy chief financial officer (CFO). Previously, Dennison was an executive vice president and the chief financial officer at Nasdaq, where she led a global team responsible for corporate finance, treasury, planning and analysis, investor relations, ESG reporting, procurement, and real estate.
Dennison will also work under current Cigna Group CFO, Brian Evanko, who will now be taking on the new role of president and chief executive officer of Cigna Healthcare. Evanko will oversee all Cigna Healthcare businesses, including U.S. Commercial, International Health, and U.S. Government.
The last addition to The Cigna Group is Eric Palmer who will expand his role to assume oversight of the Group’s Enterprise Strategy and Corporate Development. Palmer will continue to serve as president and CEO of Evernorth Health Services.
At Cigna Healthcare, Bryan Holgerson will be promoted to serve as president of U.S. Commercial by the end of 2024 once the current position is completed by Mike Triplett. Triplett plans to retire the position by the end of the year, but then transition to a new role of special advisor to the CEO where he’ll focus on solutions for key distribution channels.
While The Cigna Group implements these changes, its private foundation, The Cigna Group Foundation, continues to support the community and its children by promoting healthier habits, and focusing on the well-being of the Group itself.
In December 2023, The Cigna Group Foundation pledged almost $3.3 million to address food insecurity and enhance youth mental health, as part of its Healthier Kids For Our Future initiative that has granted $25 million to nearly 150 nonprofits in the U.S. since 2019.
Additionally, The Group’s Board of Directors agreed to spend $10 billion more on buying back their own company shares in December, bringing the company's total share repurchase authority to $11.3 billion.
In 2024, they plan to spend most of their extra funds on this buyback, more specifically, at least $5 billion on buying their own company's shares by mid-2024.
Some of this will happen quickly in the first quarter of 2024 through their accelerated share repurchase program.
DC Roundtable: Patrick Cooney of The Federal Group Drops the Latest on PBM Legislation in Washington
April 11th 2024In this episode of "DC Roundtable," Peter Wehrwein, managing editor of Managed Healthcare Executive, spoke with Patrick Cooney, president of The Federal Group, a lobbying and strategic planning firm in Washington, D.C., about recent developments in Washington concerning PBMs.
Listen
The Relationship Between ILD and MDA5 Antibody-Positive DM
May 2nd 2024Rapidly progressing interstitial lung disease in anti-melanoma differentiation-associated gene 5 (MDA5) antibody-positive dermatomyositis (DM) is known for its high death rate because it worsens quickly and causes breathing difficulties within three months of initial lung symptoms. However, there isn't much information about the timing between the diagnosis of ILD and MDA5 antibody-positive DM because most research focuses on either the frequency or the death rates rather than the timing of onset.
Read More